x
Filter:
Filters applied
- Protein Structure and Folding
- Zajonc, Dirk MRemove Zajonc, Dirk M filter
- surface plasmon resonance (SPR)Remove surface plasmon resonance (SPR) filter
Author
- Wang, Jing2
- Benedict, Chris A1
- Birkholz, Alysia1
- Bitra, Aruna1
- Chitale, Sampada1
- Croft, Michael1
- Doukov, Tzanko1
- Farber, Elisa1
- Franck, Richard W1
- Girardi, Enrico1
- Howell, Amy1
- Khurana, Archana1
- Kronenberg, Mitchell1
- Nemčovič, Marek1
- Pauwels, Nora1
- Picarda, Gaelle1
- Tsuji, Moriya1
- van Calenbergh, Serge1
- Yu, Esther Dawen1
Keyword
- cell surface receptor1
- cytokine induction1
- galectin1
- glycolipid structure1
- immunology1
- N-linked glycosylation1
- protein crystallization1
- protein structure1
- protein-protein interaction1
- recombinant protein expression1
- site-directed mutagenesis1
- T cell receptor (TCR)1
- tumor necrosis factor (TNF)1
- X-ray crystallography1
Protein Structure and Folding
2 Results
- Protein Structure and FoldingOpen Access
Crystal structure of murine 4-1BB and its interaction with 4-1BBL support a role for galectin-9 in 4-1BB signaling
Journal of Biological ChemistryVol. 293Issue 4p1317–1329Published online: December 14, 2017- Aruna Bitra
- Tzanko Doukov
- Jing Wang
- Gaelle Picarda
- Chris A. Benedict
- Michael Croft
- and others
Cited in Scopus: 254-1BB (CD137) is a TNF receptor superfamily (TNFRSF) member that is thought to undergo receptor trimerization upon binding to its trimeric TNF superfamily ligand (4-1BBL) to stimulate immune responses. 4-1BB also can bind to the tandem repeat–type lectin galectin-9 (Gal-9), and signaling through mouse (m)4-1BB is reduced in galectin-9 (Gal-9)–deficient mice, suggesting a pivotal role of Gal-9 in m4-1BB activation. Here, using sulfur-SAD phasing, we determined the crystal structure of m4-1BB to 2.2-Å resolution. - ImmunologyOpen Access
Lipid and Carbohydrate Modifications of α-Galactosylceramide Differently Influence Mouse and Human Type I Natural Killer T Cell Activation
Journal of Biological ChemistryVol. 290Issue 28p17206–17217Published online: May 27, 2015- Alysia Birkholz
- Marek Nemčovič
- Esther Dawen Yu
- Enrico Girardi
- Jing Wang
- Archana Khurana
- and others
Cited in Scopus: 14The ability of different glycosphingolipids (GSLs) to activate type I natural killer T cells (NKT cells) has been known for 2 decades. The possible therapeutic use of these GSLs has been studied in many ways; however, studies are needed in which the efficacy of promising GSLs is compared under identical conditions. Here, we compare five unique GSLs structurally derived from α-galactosylceramide. We employed biophysical and biological assays, as well as x-ray crystallography to study the impact of the chemical modifications of the antigen on type I NKT cell activation.